Dr. Paraghamian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Washington St
Boston, MA 02111Phone+1 617-636-6058Fax+1 617-636-3258
Education & Training
- University of North Carolina HospitalsFellowship, Gynecologic Oncology, 2018 - 2021
- University of California (Irvine)Residency, Obstetrics and Gynecology, 2014 - 2018
- University of North Carolina at Chapel Hill School of MedicineClass of 2014
Certifications & Licensure
- MA State Medical License 2021 - 2026
- NH State Medical License 2022 - 2026
- NC State Medical License 2018 - 2021
- CA State Medical License 2016 - 2019
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- 4 citationsLinoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer.Jianqing Qiu, Ziyi Zhao, Hongyan Suo, Sarah E Paraghamian, Gabrielle M Hawkins
Cancer Biology & Therapy. 2024-12-31 - 1 citationsPredictors of germline genetic testing referral and completion in ovarian cancer patients at a Comprehensive Cancer Center.Katherine W Saylor, Elizabeth Q Fernandes, Michael Adams, Sarah Paraghamian, David I Shalowitz
Gynecologic Oncology. 2024-07-01 - 2 citationsA novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer.Sarah E Paraghamian, Jianqing Qiu, Gabrielle M Hawkins, Ziyi Zhao, Wenchuan Sun
Cancer Biology & Therapy. 2023-12-31
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: